Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Am J Surg. 2019 Jan 3;218(1):157–163. doi: 10.1016/j.amjsurg.2018.12.067

Table 1.

Characteristics of patients with early-stage hepatocellular carcinoma who underwent surgical resection or ablation.

Characteristic Ablation
(n = 8,433)
Surgical
Resection
(n = 7,697)
P-value
Age >65 years old 3,244 (38.5%) 3,515 (45.7%) <0.001
Male 6,139 (72.8%) 5,445 (70.7%) 0.004
Race <0.001
 White 5,350 (65.0%) 4,738 (62.9%)
 Black 1,063 (12.9%) 1,113 (14.8%)
 Hispanic 1,065 (12.9%) 580 (7.7%)
 Asian 701 (8.5%) 1,061 (14.1%)
 Native American 55 (0.7%) 36 (0.5%)
Charlson/Deyo Comorbidity Score <0.001
 CDCC 0 3,635 (43.1%) 3,951 (51.3%)
 CDCC 1 2,427 (28.8%) 2,310 (30.0%)
 CDCC ≥2 2,371 (28.1%) 1,436 (18.7%)
Fibrosis score <0.001
 F0 (none to moderate fibrosis) 382 (16.4%) 1,232 (59.2%)
 F1 (severe fibrosis or cirrhosis) 1,954 (83.7%) 849 (40.8%)
Tumor size <0.001
 Tumor <3 cm 4,715 (58.8%) 1,888 (25.0%)
 Tumor 3–5 cm 2,780 (34.7%) 2,615 (34.6%)
 Tumor >5 cm 523 (6.5%) 3,045 (40.3%)
Insurance status <0.001
 Private 2,728 (32.9%) 2,878 (38.5%)
 Medicare 3,930 (47.3%) 3,550 (47.5%)
 Medicaid 1,135 (13.7%) 725 (9.7%)
 Other government 210 (2.5%) 95 (1.3%)
 None 298 (3.6%) 230 (3.1%)
Median income quartiles (by zip code) 0.001
 > $63,000 2,427 (29.2%) 2,332 (30.7%)
 $48,000 – $62,999 2,293 (27.6%) 2,016 (26.5%)
 $38,000 – $47,999 1,810 (21.8%) 1,780 (23.4%)
 < $38,000 1,777 (21.4%) 1,468 (19.3%)
Education level* 0.10
 Higher education level (<7%) 1,651 (19.9%) 1,585 (20.9%)
 7% – 12.9% 2,434 (29.3%) 2,292 (30.2%)
 13% – 20.9% 2,277 (27.4%) 2,028 (26.7%)
 Lower education level (≥21%) 1,954 (23.5%) 1,694 (22.3%)
Facility type <0.001
 Community cancer program 141 (1.7%) 208 (2.8%)
 Comprehensive community cancer program 1,462 (17.5%) 1,604 (21.5%)
 Academic/research program 5,847 (69.8%) 4,873 (65.5%)
 Integrated network cancer program 929 (11.1%) 760 (10.2%)
Facility region <0.001
 New England/Mid Atlantic 2,175 (26.0%) 1,875 (25.2%)
 South Atlantic 1,395 (16.7%) 1,518 (20.4%)
 North Central 1,507 (18.0%) 1,569 (21.1%)
 South Central 1,289 (15.4%) 1,206 (16.2%)
 Mountain 319 (3.8%) 245 (3.3%)
 Pacific 1,694 (20.2%) 1,032 (13.9%)
Distance between patient zip code and hospital 0.82
 <10 miles 3,304 (39.2%) 3,040 (39.5%)
 10–40 miles 2,738 (32.5%) 2,508 (32.6%)
 >40 miles 2,391 (28.4%) 2,149 (27.9%)
Year of diagnosis 0.043
 2004 – 2009 3,015 (35.8%) 2,870 (37.3%)
 2010 – 2014 5,418 (64.3%) 4,827 (62.7%)
>30 days between diagnosis and procedure 6,191 (73.4%) 4,558 (59.2%) <0.001
LOS after procedure (days, mean) 2.12 7.19 <0.001
30-day unplanned readmissions 189 (2.3%) 382 (5.1%) <0.001

CDCC: Charlson/Deyo Comorbidity Score; LOS: length of stay

*

Percent of region without high school degree